Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Am J Respir Crit Care Med. 2010 Sep 15;182(6):797-804. doi: 10.1164/rccm.201001-0080OC. Epub 2010 May 27.
Mycoplasma pneumoniae was recently discovered to produce an ADP-ribosylating and vacuolating cytotoxin, designated CARDS toxin, which is hypothesized to be a primary pathogenic mechanism responsible for M. pneumoniae-induced pulmonary inflammation. It is unknown if cytotoxin production varies with M. pneumoniae strain or if variation in cytotoxin production affects pulmonary disease severity.
To examine the production of CARDS toxin by various strains of M. pneumoniae and compare the disease manifestations elicited by these strains in an experimental model of M. pneumoniae respiratory infection.
BALB/c mice were inoculated once intranasally with SP4 broth (negative control) or three different M. pneumoniae strains: M129-B7, M129-B9, or S1. Mice were assessed at 1, 2, 4, 7, 10, and 14 days after inoculation. Outcome variables included comparisons among M. pneumoniae strains relative to bronchoalveolar lavage (BAL) M. pneumoniae quantitative culture, CARDS toxin-based PCR, and CARDS toxin protein determinations, as well as cytokine and chemokine concentrations. Graded lung histopathologic score (HPS) was also assessed.
CARDS toxin concentrations were significantly increased in mice inoculated with strain S1 compared with mice inoculated with M129-B7 or M129-B9 strains. Quantitative M. pneumoniae culture and polymerase chain reaction were also significantly greater in mice infected with S1 strain compared with the other two strains, as were lung HPS and concentrations of IFN-γ, IL-12, IL-1α, macrophage inflammatory protein-1α, and keratinocyte-derived chemokine. In addition, a significant positive correlation was found between CARDS toxin concentration and lung HPS.
CARDS toxin concentrations in BAL are directly linked to the ability of specific M. pneumoniae strains to colonize, replicate, and persist, and elicit lung histopathology. This variation among strains may predict the range in severity of pulmonary disease observed among patients.
肺炎支原体最近被发现能产生一种 ADP-核糖基化和空泡化细胞毒素,称为 CARDS 毒素,该毒素被认为是肺炎支原体引起肺部炎症的主要致病机制。目前尚不清楚细胞毒素的产生是否因肺炎支原体菌株的不同而不同,或者细胞毒素产生的差异是否会影响肺部疾病的严重程度。
检测各种肺炎支原体菌株产生 CARDS 毒素的情况,并比较这些菌株在肺炎支原体呼吸道感染实验模型中引起的疾病表现。
BALB/c 小鼠经鼻腔接种一次 SP4 肉汤(阴性对照)或三种不同的肺炎支原体菌株:M129-B7、M129-B9 或 S1。在接种后 1、2、4、7、10 和 14 天对小鼠进行评估。观察指标包括比较肺炎支原体菌株之间的支气管肺泡灌洗液(BAL)肺炎支原体定量培养、基于 CARDS 毒素的 PCR 以及 CARDS 毒素蛋白测定结果,同时评估细胞因子和趋化因子浓度。还评估了分级肺组织病理学评分(HPS)。
与接种 M129-B7 或 M129-B9 菌株的小鼠相比,接种 S1 菌株的小鼠 CARDS 毒素浓度显著升高。与其他两株相比,感染 S1 株的小鼠定量 M. pneumoniae 培养和聚合酶链反应也显著增加,肺 HPS 以及 IFN-γ、IL-12、IL-1α、巨噬细胞炎症蛋白-1α 和角质细胞衍生的趋化因子浓度也显著增加。此外,还发现 CARDS 毒素浓度与肺 HPS 之间存在显著的正相关。
BAL 中的 CARDS 毒素浓度与特定肺炎支原体菌株定植、复制和持续存在以及引起肺部组织病理学的能力直接相关。菌株之间的这种差异可能预测患者中观察到的肺部疾病严重程度的范围。